First Time Loading...

Harvard Bioscience Inc
NASDAQ:HBIO

Watchlist Manager
Harvard Bioscience Inc Logo
Harvard Bioscience Inc
NASDAQ:HBIO
Watchlist
Price: 3.85 USD 0.79% Market Closed
Updated: May 6, 2024

Harvard Bioscience Inc
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Harvard Bioscience Inc
Net Income (Common) Peer Comparison

Comparables:
TMO
DHR
WST
A
IQV

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Harvard Bioscience Inc
NASDAQ:HBIO
Net Income (Common)
-$3.4m
CAGR 3-Years
24%
CAGR 5-Years
-3%
CAGR 10-Years
-6%
Thermo Fisher Scientific Inc
NYSE:TMO
Net Income (Common)
$6B
CAGR 3-Years
-2%
CAGR 5-Years
15%
CAGR 10-Years
17%
Danaher Corp
NYSE:DHR
Net Income (Common)
$8.1B
CAGR 3-Years
21%
CAGR 5-Years
27%
CAGR 10-Years
12%
West Pharmaceutical Services Inc
NYSE:WST
Net Income (Common)
$568.7m
CAGR 3-Years
10%
CAGR 5-Years
21%
CAGR 10-Years
18%
Agilent Technologies Inc
NYSE:A
Net Income (Common)
$1.2B
CAGR 3-Years
15%
CAGR 5-Years
2%
CAGR 10-Years
5%
IQVIA Holdings Inc
NYSE:IQV
Net Income (Common)
$1.4B
CAGR 3-Years
69%
CAGR 5-Years
39%
CAGR 10-Years
20%

See Also

What is Harvard Bioscience Inc's Net Income (Common)?
Net Income (Common)
-3.4m USD

Based on the financial report for Dec 31, 2023, Harvard Bioscience Inc's Net Income (Common) amounts to -3.4m USD.

What is Harvard Bioscience Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
-6%

Over the last year, the Net Income (Common) growth was 64%. The average annual Net Income (Common) growth rates for Harvard Bioscience Inc have been 24% over the past three years , -3% over the past five years , and -6% over the past ten years .